Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ocular Therapeutix Inc. logo

Ocular Therapeutix Inc.

Sector: Healthcare   

Industry: Biotechnology

9.10
 
USD
  
-0.21
  
(-2.26%)
Optionable: Yes  Market Cap: 1,367 M  90-day average vol: 2,086,604

Previous close: 9.31  Open: 9.3  Bid: 9.06  Ask: 9.5
52 week range    
2.00   
   11.31
Peers   
XENT / 
ANIK / 
HAE / 
Last updated: Friday 29th March 2024
49
MarketXLS Rank
40
Value
53
Technical
55
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ANIK

0 B-77.630.71

HAE

2 B80.646.97

SRDX

1 B152.341.38

XENT

1 B-10.227.31
Financials

OCUL Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock11000.0
Basic EPS from continuing operations-1.91-2.56-0.09-0.92-1.01
Basic EPS total-0.42-1.91-2.56-0.09-0.92-1.01
Basic weighted shares outstanding11 M23 M25 M29 M38 M45 M61 M76 M77 M80 M
Cost of sales-91000.0-319000.0-443000.0-457000.0-465000.02 M2 M4 M5 M5 M
Depreciation-547000.0-754000.0-881000.0-2 M-2 M3 M3 M2 M2 M3 M
DepreciationAndAmortization-547000.0-754000.0-881000.0-2 M-2 M3 M3 M2 M2 M3 M
Diluted EPS total-2.69-1.71-1.8-2.2-1.57-1.91-2.56-0.98-0.97-1.02
Diluted normalized net income/share-0.98-0.97-1.02
Diluted weighted shares outstanding11 M23 M25 M29 M38 M45 M82 M83 M86 M
GainOnSaleOfSecurity6 M-86 M78 M798000.04 M
GeneralAndAdministrativeExpense7 M9 M11 M16 M19 M22 M23 M32 M32 M34 M
Gross operating profit681000.01 M1 M1 M2 M2 M15 M39 M47 M53 M
Income before tax-29 M-40 M-45 M-63 M-60 M-86 M-156 M-7 M-71 M-81 M
Income restructuring and M&A-3 M3 M
Interest income4 M5 M4 M
InterestExpenseNonOperating1 M2 M2 M2 M2 M6 M7 M7 M7 M11 M
MiscOtherSpecialCharges-442000.07000.0-1000.05000.0-8000.01000.014 M9 M
Net income from total operations-29 M-40 M-45 M-63 M-60 M-86 M-156 M-7 M-71 M-81 M
NetIncomeCommonStockholders-29 M-40 M-45 M-63 M-60 M-86 M-156 M-7 M-71 M-81 M
NetIncomeContinuousOperations-29 M-40 M-45 M-63 M-60 M-86 M-156 M-7 M-71 M-81 M
NetNonOperatingInterestIncomeExpense-1 M-2 M-1 M-1 M-860000.0-6 M-7 M-7 M-7 M-11 M
Normalized income-64 M
Operating income-27 M-38 M-43 M-62 M-59 M-86 M-63 M-78 M-79 M-82 M
Operating income before depreciation (EBITDA)-27 M-37 M-42 M-59 M-56 M-74 M-142 M7 M-57 M-60 M
OperatingExpense-28 M40 M45 M63 M61 M88 M78 M117 M126 M136 M
Other income net442000.0-7000.01000.0-5000.0-6 M86 M-78 M-15 M-13 M
OtherGandA7 M9 M11 M16 M19 M22 M23 M32 M32 M34 M
OtherOperatingExpenses3 M3 M3 M3 M4 M
OtherunderPreferredStockDividend11000.0
PreferredStockDividends11000.0
PromotionAndAdvertising2 M1 M880000.0
RentAndLandingFees7 M9 M11 M16 M19 M
Research & development expense19 M27 M27 M31 M37 M41 M29 M50 M53 M61 M
ResearchExpense19 M27 M27 M31 M37 M41 M29 M50 M53 M61 M
RestructringAndMnAIncome-3 M3 M
SalariesAndWages-3 M-5 M-6 M-7 M-7 M9 M8 M
Selling Gen & administrative expense9 M13 M18 M33 M24 M47 M49 M67 M72 M74 M
SellingAndMarketingExpense2 M4 M7 M17 M5 M24 M27 M35 M40 M41 M
SellingExpense2 M4 M7 M17 M5 M
Special income/charges3 M-3 M
Total Income available for interest expense (EBIT)-28 M-38 M-43 M-61 M-58 M-80 M-149 M118000.0-64 M-69 M
Total common shares outstanding21 M25 M29 M37 M43 M53 M76 M77 M78 M149 M
Total net income-29 M-40 M-45 M-63 M-60 M-86 M-156 M-7 M-71 M-81 M
Total ordinary shares149 M149 M149 M149 M149 M149 M149 M149 M149 M149 M
Total revenues772000.02 M2 M2 M2 M4 M17 M44 M51 M58 M
TotalExpenses-28 M39 M44 M63 M60 M90 M80 M122 M130 M141 M
TotalRevenue460000.01 M2 M2 M2 M4 M17 M44 M51 M58 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University